At the forefront of key areas of international health economics research, such as the challenges of obesity and nutrition and pharmaceutical innovation, the Centre for Health Economics and Policy Innovation (CHEPI) is regarded as one the Business School’s most successful research centres. The focus of the Centre’s work is on incentives that drive productivity, quality, and innovation in the health system and at organisational levels.
CHEPI is currently a partner to three large-scale, multi-million pound, European projects that launched in 2023 in this area: CoDiet (led by Imperial College Faculty of Medicine), JACARDI, and OBCT. The Centre was awarded funding from the Gatsby Foundation to explore innovation and productivity, particularly in the pharmaceutical industry and is a partner to the European Commission funded project Hi-Prix, investigating pharmaceutical pricing and payment mechanisms. The range of funding secured by the Centre contributed to the Business School’s 100% rating in REF 2021 for Research environment.
CHEPI continues to host high-profile debates at the intersection between research and policy, working with influential leaders such as the World Bank, WHO, and George Institute. Notably running the Leadership in Global Health roundtable with speakers including former Prime Minister of New Zealand Rt. Hon. Helen Clark, and Dr. Sania Nishtar, member of the Senate of Pakistan.
The work of the Centre for Health Economics and Public Policy is instrumental in the success of the wider research taking place at Imperial College Business School.
With best wishes
Prof. Franklin Allen Interim Dean
Imperial
College Business School
Foreword
Our previous CHEPI report was written at the height of the Covid-19 pandemic, when Universities and research centres like ours were trying to redefine not only their research agenda, but also their wider approach to research and impact generation. In the years that followed, CHEPI has taken stock of those tumultuous developments and has set off on a new path of growth and expansion, with an increased emphasis on producing policy-relevant research that can make a difference in a complex world, facing unprecedented challenges.
Dire predictions about the unsustainability of even the most advanced health care systems have begun to turn into a grim reality after the pandemic in countries at all levels of income, with access to essential services becoming increasingly difficult for many, amid soaring waiting times, staff shortages, organisational inefficiency, slow productivity growth and financing challenges. This context has made CHEPI’s mission, if possible, even more relevant and important. We have doubled down on our efforts to research incentives that can keep people healthy and make health care systems efficient, equitable and sustainable. We have made our research even more relevant by engaging with stakeholders and the wider public, and we have further strengthened our capability to convey the findings of our research to key audiences and users.
In this report, we illustrate the breadth and depth of CHEPI’s contributions over the past two years, achieved through the hard work of its faculty, staff and PhD students, and leveraging old and new strategic partnerships within and beyond Imperial College. CHEPI is now established as a reference point for health economics and policy at Imperial, with a strong national and international presence in key areas of this vast field of research. In particular, CHEPI’s world class research and policy impacts in areas such as food and obesity policy, health taxes, health care labour and productivity, pharmaceutical innovation, climate change, air pollution and health has provided the basis for policy actions and recommendations by national and international agencies. This has contributed to making CHEPI’s research agenda more prominent, generating in turn new research grant opportunities.
Reflecting the international nature of CHEPI’s research, a significant proportion of our grants continue to come from sources that typically fund European or global research. Despite the recent uncertainties, CHEPI has been very successful in securing funding and participation in EU projects. This includes being part of Programmes in which the UK as a country has chosen not to participate. In the past two years, we have also consolidated and expanded our research on diet, nutrition and non-communicable diseases policies in South Asia.
CHEPI’s greatest asset is the people who work in the Centre. CHEPI’s Faculty, staff and PhD students have gone from strength to strength in the past years. Marisa Miraldo and Laure de Preux have obtained important career recognitions, rising to senior faculty roles; Sam Burn has joined our Faculty as Assistant Professor; Elisa Pineda and Mario Martinez-Jimenez have been awarded prestigious Imperial College Research Fellowships; Anita Patel has been appointed in the Provost’s Visting Professor Programme; Christa Hansen and Alexa Segal have successfully completed their PhDs; Bernardo Andretti, Daniel Laydon, Sonia Mun, Mariia Murasheva, Chuanzi Yue, Jingmin Zhu have joined our research staff; Heather Lodge has joined our Centre management team. What you will read in this report is the result of their hard work and dedication.
Prof. Franco Sassi Centre Director CHEPI
Prof. Franco Sassi
Centre Director, Professor of International Health Policy & Economics
Impacts of public policies to tackle major chronic diseases and their predisposing risk factors, including poor nutrition physical inactivity, alcohol and tobacco use, environmental and social determinants, physical inactivity, alcohol and tobacco use.
Prof. James Barlow
Professor
of Technology & Innovation Management (Healthcare)
Adoption, implementation and sustainability of innovation in healthcare systems.
Dr. Sam Burn Assistant Professor in Economics and Public Policy
Using public policy to improve equity of access to health care and health outcome; interaction of the public and private sectors in financing and provision of healthcare
Katharina Hauck Professor in Health Economics (School of Public Health)
Economics of HIV/AIDS, the impact of epidemics, the evaluation of health interventions, and the role of behaviour in the transmission of infectious disease.
Prof.
Prof. Marisa Miraldo Academic Director, Global Health Management MSc / Professor of Health Economics
Determinants of innovation in the pharmaceutical sector, determinants of the adoption and diffusion of innovation and the impact of policy and regulation on pharmaceutical firms’ strategies.
Prof. Anita Patel
Imperial College London Provost’s Visiting Professor
Evaluation of stroke rehabilitation and mental healthcare
Dr. Laure de Preux Associate
Professor of Economics
Determinants of health, the evaluation of climate change related policies, and the impact of climate and pollution on health and the healthcare sector
Prof. Dame Carol Propper Professor of Economics (DBE, FBA) International Fellow, NAM, President of the Royal Economic Society
Impact of incentives on the quality and productivity of healthcare, the effect of market incentives on the production of public services and the impact of environmental factors on health.
Dr. Pedro Rosa Dias
Associate Professor of Health Economics
Health economics in developing countries, inequalities in health and healthcare and the effects of educational policy on health outcomes.
Dr.
Reza
Skandari Assistant Professor of Health Operations
Optimising healthcare design decisions, ranging from treatment plans to health policies.
Research staff
Dr. Bernado Andretti Research Associate
Dr. Grazia Antonacci
Research Associate (with School of Public Health)
Arianna Gentilini Research Assistant
Dr. Mario Martinez-Jimenez
Imperial College Research Fellow International Health Economics Association Congress Early Career Researcher Best Paper Prize 2023.
Sonia Mun Research Assistant
Dr. Nalinda Wellappuli Research Associate
Dr. Chuanzi Yue Research Associate
Dr. Jingmin Zhu Research Associate
Professional staff
Dr. Mariia Murasheva Research Associate
Dr. Elisa Pineda
Imperial College Research Fellow (The George Institute UK)
Dr. Cristina Taddei
Imperial College Research Fellow
Dr. Zoey Verdun Research Associate
Dr. Jack Olney Executive Director
Lorraine Sheehy Executive Assistant to Director of Centre & Centre Administrator
Heather Lodge Project Coordinator
Honorary staff
2022–23
Dr. Annalisa Belloni Cancer Research UK
Dr. Tim Lobstein World Obesity Federation
Dr. Karen Watson Strategic Communications Consultant
Our research
We continue to develop our interests in the global challenges of obesity and policy innovations around healthy taxation and product reformulation. We have supported work on pharmaceutical innovation and productivity as well as examining the impacts of climate change on health. Following our Covid-related work, we are now participating in a four-year project on pandemic global preparedness.
Global challenges of obesity and nutrition
CHEPI completed its highly successful project on Science and Technology in childhood Obesity Policies (STOP) at the end of 2022. Funded by the European Commission’s Horizon 2020 Programme, the four-year study involved 24 organisations across Europe, the USA, and New Zealand. It identified critical stages in childhood where sustainable policies could be implemented to prevent obesity, particularly among can be implemented to prevent obesity, particularly among socially disadvantaged children. Outputs from STOP have been used widely in academic and policy settings, including, among others, Parliamentary inquiries and EU Council Presidency events. STOP was profiled by the EC’s Horizon Magazine in March 2024, looking at the project’s legacies in terms of school meals.
In collaboration with the World Health Organization (WHO), STOP produced six policy briefs covering physical activity in schools, reformulating foods high in fats, salt or sugar, promoting healthy eating in schools, protecting children from harmful marketing, front of pack nutrition labels, and fiscal policies that support healthy diets. STOP also published 60 peer-reviewed publications for researchers. Reflecting on STOP as Principal Investigator, Prof. Franco Sassi described the project as “a fantastic collaboration between researchers, civil society and government organisations, all passionate about advancing our knowledge and understanding of the determinants of childhood obesity, and policies for addressing it.”
See: stopchildobesity.eu
Following on from STOP, Prof. Sassi is leading work packages for three new projects funded through the European Commission Horizon Europe Programme that begin in the last year. These projects enable CHEPI to
continue developing its Health-GPS policy simulation model designed to estimate the future impacts of measures to tackle non-communicable diseases such as cancer, heart disease, diabetes, and obesity in the population of a given country or subnational jurisdiction.
Health-GPS is being used in the three-year CoDiet study to assess the impact of diet on the incidence of non-communicable disease. It will model the impacts of policies on front-of-pack labelling, marketing restrictions to children, food composition targets for processed foods and policies in schools to promote healthy food choices in six EU states. See: codiet.eu
Joint Action on CARdiovascular diseases and Diabetes (JACARDI) involves 77 partners across 21 European countries to pilot a wide range of measures to tackle chronic conditions such as heart disease and diabetes. Uniquely, JACARDI is seeking to apply a common methodology and implementation process in each country to test the ability of pilot projects to deliver effective efficient and equitable solutions for CVD and diabetes. See: jacardi.eu
The third project using the Health-GPS model is OBCT – Obesity: Biological, socio-Cultural, and environmental risk Trajectories. This five-year project involves 12 partner organisations. CHEPI will be estimating the impacts of changes in risks on incidence and prevalence as well as look at economic and social outcomes by gender and socioeconomic position. See: obct.nl
Prof. Marisa Miraldo is leading CHEPI’s input into a fiveyear study into Diabetes and Cardiovascular Disease in South Asians. Funded by the National Institute for Health and Care Research (NIHR), this project aims to improve the prevention and treatment for people with diabetes and cardiovascular disease in Bangladesh, India, Pakistan, and Sri Lanka where the impact of these chronic conditions is
STOP policy briefs, 2022 World Health Organization
made worse by poor access to high quality health and care services. Prof. Miraldo and Dr. Zoey Verdun made a recent visit to Sri Lanka as part of CHEPI’s role to implement and evaluate a “happy village” intervention that covers schools and food retailers, in two pilot sites in Gampaha in the Western Province. Researchers will also be assessing government policies aimed at tackling non-communicable diseases in India, Pakistan and Bangladesh, and Sri Lanka. See: ghru-southasia.org/projects/policy-andenvironmental-interventions
Healthy taxation
Health taxes: policy and practice, co-edited by Prof. Franco Sassi in collaboration with the World Health Organization, was published in 2022. The authors discuss the design and implementation of health taxes. They argue that policymakers across government should move on from viewing such taxes as negative “sin taxes” that stigmatise consumer behaviours to consider the broad range of positive individual and societal benefits from implementing health taxes. The book was launched in Europe by the WHO in June 2022 at a seminar with Henry Dimbleby, author of the UK National Food Strategy, and presented to the Americas by the World Bank in November 2022 at an seminar attended by 250 academics and expert groups. The World Bank used the book in its 2023 review of Armenia’s public spending.
Prof. Sassi has been leading three projects under the theme of healthy taxation. These studies explore the impacts of product reformulation and the potential for fiscal incentives to change consumer choices over dietary purchases, using both the UK and India as case studies.
CHEPI completed the second year of its project investigating Fiscal INCentives for Consumer Health (FINCH) in 2023. The project looks at how tax on food and drinks can be changed to create incentives for people to buy foods and drinks that are better for their health. Researchers are modelling the impacts of alternative tax policies for food and non-alcoholic beverages on: household expenditure and disposable income; individual dietary intakes; dietrelated morbidity, mortality and quality-adjusted life expectancy; indirect tax revenues; and, tax administration and compliance cost.
A significant output from FINCH in 2024 will be the publication of a new, open-access, dataset for researchers. The UK Food and Nutrient consumption in 2018/19: combined dataset statistically matching the Living Cost and Food Survey (LCFS) with the National Diet and Nutrient Survey (NDNS) will be available through the UK Data Archive. This unique resource brings together two separate databases to create a single source of sociodemographic information on household food expenditure and the nutritional quality of food purchases.
Alongside this, CHEPI has been consulting with the general public to test knowledge and acceptability of food taxes to improve health. A survey of 2000 members of the public was conducted by YouGov in April 2024. Results of this survey were submitted for peer-reviewed publication in July 2024. Thanks are due to the FINCH Public Reference Group for its ongoing support of the research. FINCH is funded by the National Institute for Health and Care Research (NIHR) for three years.
Some of the Happy Village team discuss implementation plans
In a study funded by the US charity Resolve to Save Lives, CHEPI researchers have tested the potential use of a novel food taxation approach, akin to the one assessed in FINCH, in India. CHEPI has developed a food demand model to assess how households at different levels of income in India would change their food purchases if GST tax rates on different types of foods were aligned with the foods’ nutritional quality. Predicted changes in food purchases were used to estimate health impacts for India’s population, based on CHEPI’s Health-GPS model.
In a spinoff study from the STOP project, CHEPI researchers are investigating the impact of the UK’s Soft Drinks Industry Levy, commonly called the “Sugar Tax”, on sugar levels in soft drinks in the UK market. The study relies on market research data from a large consumer panel. It looks at factors that drove beverage manufacturers’ decisions to reformulate (or not to reformulate) their products following the announcement of the tax. In addition, the study looks at consumer responses to beverage reformulation, assessing whether a reduced sugar content has led consumers to switching to different beverages or changing the quantity of beverages they consume. The findings are being prepared for publication.
Innovation and productivity
Through his extensive expertise in technology and innovation management in healthcare and other sectors, Prof. James Barlow was instrumental in securing the second largest philanthropic grant ever received by Imperial College. The Gatsby Charitable Foundation award is for £29m over 10 years to establish the Centre for Sectoral Economic Performance. This joint initiative between Imperial College Business School and Imperial’s Faculty of Engineering aims to improve the competitiveness of key sectors of the UK economy, including the life sciences and healthcare, by investigating the factors that impede or support their future performance and translating this research into policy and industry recommendations. Prof. Marisa Miraldo will lead one of the early projects funded by the Centre to explore the R&D productivity of the UK biopharma sector. See: imperial. ac.uk/news/250160/imperial-launches-centre-sectoraleconomic-performance
Prof. Marisa Miraldo is leading a work package for the Europewide Health Innovation Next Generation Pricing Models (Hi-Prix) Consortium. In partnership with i3Health, Prof. Miraldo is looking at how pharmaceutical innovation is affected by government policies, regulation, and market-based mechanisms. The aim is to ensure that:
1. Pharmaceutical innovation is supported in key areas of need by public and private innovators.
2. Policies and regulation do not hinder global access to those innovations in countries with different levels of income and affordability.
The Hi-Prix project is a three-year project that runs from January 2023 – December 2025. It is coordinated by Bocconi University in Italy and involves 18 organisations from 10 European countries. One of the project’s early outcomes is the publication of a “Pay for Innovation Observatory.” This unique catalogue lists details of schemes around the world that support the development of new drugs and medicinal products.
See: p4i.hiprixhorizon.eu
In concluding a two-year study into biopharmaceutical innovation and productivity, Prof. James Barlow recommended a set of twelve policy actions across business, research, manufacturing and skills, and regulation. These include the need for transparency and reporting of R&D investment into new drugs; data linkages and interoperability; the need to review the mechanisms for supporting the adoption of healthcare innovations; upskilling of personnel in data science; and the need to monitor the impact of regulation on UK performance in the sector. Findings from the study are discussed in an article in Nature Briefing. The project was funded by the Gatsby Charitable Foundation.
Prof. Dame Carol Propper worked with the Institute for Fiscal Studies to explore the senior doctors’ labour market, following reforms to public sector pensions. The study found that, despite much opposition to the changes because of the reduction in pension benefits, there was a small increase in labour supply instead of the anticipated fall in workforce numbers. This may be attributed to the fact that there are few job options for specialist NHS doctors other than private practice. The authors warn that pension reforms may yet have an impact on doctors’ entry into the NHS workforce.
There is a consensus among the scientific community that current climate policies fall short of effectively reducing greenhouse gas (GHG) emissions to achieve the necessary decarbonisation for Net Zero by 2050. One reason for governments’ reluctance to impose stricter penalties on GHG emissions is the perception that the cost of reduction exceeds the benefits, especially within their short tenure horizon.
However, evidence suggests that carbon pricing not only reduces GHG emissions and promotes green innovation, but may also offer additional co-benefits such as local air quality improvement. This could have direct benefits to the local population. Policymakers overlook these benefits due to a lack of evidence that can quantify them plausibly. Dr. de Preux, affiliated with CHEPI, and her co-author, Prof. Ulrich Wagner, are addressing this challenge by constructing a unique dataset that compiles information about industrial emitters, power producers, carbon pricing, and other socio-economic data. They model and quantify potential air quality improvements associated with these policies. Their modelling strategy distinguishes itself by considering firm heterogeneity in emission reduction and its impacts on other co-pollutants.
Global preparedness
The Jameel Institute-Kenneth C. Griffin Initiative for the Economics of Pandemic Preparedness was launched in October 2022. This is a key interdisciplinary research programme in collaboration between the School of Public Health and the Business School that builds on the research that was awarded a Queen’s Anniversary Award. It will provide critical data and analysis to inform public health decisions related to pandemic preparedness and disease outbreaks around the world.
The project will produce a publicly available dashboard that shows levels of preparedness in over 150 countries, as well as deep-dive studies on specific preparedness interventions.
Prof. Marisa Miraldo is leading on the Business School contribution. CHEPI will be working with the Jameel Institute, Imperial College London School of Public Health, the World Health Organization, Singapore’s PREPARE program, and Umeå University in Sweden. The project runs until November 2027.
University research is assessed every seven years through the Research Excellence Framework. A significant part of the assessment focuses on the extent of engagement and impact that research achieves outside the academic environment. One way of gauging impact is to look at how research is being used by governments and the organisations who influence government policymaking. Over the period of this annual report, publications by CHEPI’s senior researchers, Prof. James Barlow, Prof. Marisa Miraldo, and Prof. Franco Sassi were cited in policy documents* by:
19 governments across Africa, Asia, Australia, Europe, and North America.
24 international agencies such as WHO, World Bank, UN
20 think tanks / national organisations
6 clinical / health care organisations.
A case study of publications from the STOP project The STOP project has been particularly successful in attracting the attention of policymakers. We explored this by using citation analysis* to find policy documents from 2022-2024 that quoted research published by Imperial College researchers as part of the STOP project.
Evidence from STOP was used by nine countries: Australia, Belgium, Denmark, Italy, South Africa, Spain, Sweden, Switzerland, and UK. A total of sixteen policy reports were published in the past 18 months, covering food reformulation, obesity management, consumer food choices, and children.
The difficulty of translating research into policy in the UK is underlined by the fact that 81% of reports using STOP evidence in 2022–24 were from international governments or agencies.
Organisations citing STOP publications in 2022–24
44% International agency
37% International government
13% Goverment
6% UK policy organisations
The STOP publications quoted in policy documents during 2022–24 were:
Chambers T, Segal A, Sassi F. Interventions using behavioural insights to influence children’s diet-related outcomes: a systematic review. Obes Rev 2021; 22(2): e13152 doi.org/10.1111/obr.13152
Gressier M, Sassi F, Frost G. Contribution of reformulation, product renewal, and changes in consumer behavior to the reduction of salt intakes in the UK population between 2008/2009 and 2016/2017. Am J Clin Nutr 2021; 14(3): 1092-1099 doi.org/10.1093/ajcn/nqab130
Gressier M, Sassi F, Frost G. Healthy foods and healthy diets. how government policies can steer food reformulation. Nutrients 2020; 12(7), 1992 doi.org/10.3390/nu12071992
Gressier M, Swinburn B, Frost G, Segal AB, Sassi F. What is the impact of food reformulation on individuals’ behaviour, nutrient intakes and health status? A systematic review of empirical evidence. Obes Rev 2021 Feb; 22(2):e13139. doi.org/10.1111/obr.13139.
Pineda E, Bascunan J, Sassi F. Improving the school food environment for the prevention of childhood obesity: What works and what doesn’t. Obes Rev 2021 Feb;22(2):e13176. doi: 10.1111/obr.13176. 22(2): e13139 doi.org/10.1111/obr.13139
* Policy documents citing CHEPI authors were obtained through the Overton policy database trialled by Imperial College London January –February 2024.
Communicating CHEPI’s research
CHEPI hosted a roundtable discussion on global leadership in health in September 2023 that was attended by 100 participants in person and many more online. This event was jointly organised with the George Institute UK and the Saw Swee Hock School of Public Health, Singapore. The panel leading the discussions included the Rt. Hon. Helen Clark, former Prime Minister of New Zealand, Dr. Richard Horton, Editor-in-Chief of The Lancet, Dr. Ebere Okereke, CEO of the Africa Public Health Foundation, and Ms Afifah Ismat Rahman-Shepherd of the Saw Swee Hock School of Public Health. Topics debated covered a number of issues, ranging across the challenges arising from pandemics, the need to tackle noncommunicable diseases, the links between poverty, health and the economy, and the sustainability of health systems.
CHEPI researchers engage widely to present their work. For example Prof. James Barlow led a workshop on Rethinking healthcare environments at the International Forum on Quality and Safety in Healthcare, in Copenhagen, May 2023 which was attended by 400 participants. Presenting CHEPI work at conferences is encouraged as a means of increasing CHEPI’s connections with global research communities as well as being an essential aspect of academic career development. Conference presentations have increased by 18% since 2021/22 with CHEPI researchers having presented their work at 60 national and international conferences and workshops, covering nineteen countries across five continents, in 2022–23.
CHEPI’s research was profiled in the national and international media during 2022–24.
For example, The Guardian, Daily Telegraph, Daily Mail, Irish Independent, and Fortune all covered research by Alexa Segal, Laure de Preux, and Marisa Miraldo on the impact of parenting styles on children’s weight. The work was presented at the International Congress on Obesity in Melbourne in October 2022.
In March 2024, Prof. Franco Sassi was interviewed by RAI, the Italian national broadcasting company, on health taxes as an effective policy measure to tackle obesity. This was part of a TV programme looking at the proposed sugar tax in Italy.
CHEPI researchers contribute to Parliamentary inquiries and political briefings as these arise. In March 2024, for example, Prof. Franco Sassi gave oral evidence to the House of Lords inquiry into food, diet and obesity. In February 2023, Prof. James Barlow gave evidence on innovation in healthcare infrastructure to the All Party Parliamentary Group on Healthcare Infrastructure as part of its inquiry and also at a health and social care briefing with the Liberal Democrats. CHEPI researchers also provide expert comment for national and professional media. For example:
Prof. James Barlow gave interviews to Raconteur, Politico, Le Temps, and Med Tech World on the UK pharmaceutical industry, particularly in relation to Brexit.
Prof. Marisa Miraldo was interviewed for Expresso on innovations in health and healthcare.
Prof. Franco Sassi was interviewed by the daily Spanish newspaper El Pais (photo above) about childhood obesity, following a high level meeting arranged by the Ministry of Health in Palma on policies to tackle childhood obesity.
Prof. Franco Sassi was interviewed in The Guardian in November 2023 to provide expert analysis of the new tax introduced in Colombia on ultra-processed foods.
Prof. Dame Carol Propper participated in NESTA’s Minister of the Future in November 2023 to discuss future healthcare.
Prof. Franco Sassi was interviewed by The Telegraph in February 2024 on international policies to combat obesity.
Senior CHEPI staff share their expertise through invitations to serve on external committees, both nationally and
internationally. This extends CHEPI’s reach and helps to deliver our goal of supporting policies that embed the incentives that will lead to healthier lives. For example:
Prof. James Barlow served on:
– the International Scientific Advisory Committee, AGEWELL Canada
– the Steering Board of the Industry Commons Foundation, Sweden.
Prof. Marisa Miraldo served as:
– Associate Editor of Journal of Behavioural and Experimental Economics
– Editor for BMJ Public Health
– Guest Editor for BMC Medicine.
Dr. Laure de Preux, Assistant Professor, served on:
– COMEAP/QUARK ad-hoc group on economic valuation of morbidity related to air pollution, UK Health Security Agency
– WHO Advisory Group on Economics for Environment, Climate Change and Health.
Prof. Dame Carol Propper served on:
– Council for Science and Technology, UK – UK Statistics Authority Board.
Our MSc in International Health Management continues to attract high numbers of students. The 2022–23 cohort of 97 students was a 38% increase on numbers in 2019–20. Of the 44% of students who took up employment in the consultancy sector on graduation, 69% did so in healthcare consultancy. Our current cohort comes from 23 different countries with 34% of students coming from Asia-Pacific.
The masters’ degree has been redesigned for the next intake in September 2024 to become the Global Health Management MSc. The revised course will be highly interdisciplinary and designed to reflect changing developments in global healthcare following Covid, the fall-out from the economic crisis, and rapidly developing technologies.
Our sincere thanks go to Dr. Benita Cox for having led the MSc so effectively. Following Benita’s move to a new role within Imperial Business School, Prof. Marisa Miraldo, Professor of Economics, was appointed Academic Director for this course.
Executive Education, Academic Leadership, and Healthcare Leadership Development
Prof. James Barlow leads two courses within the Executive Education programme:
1. Digital Transformation in Healthcare: Innovation, Strategies, and Processes. Around 100 participants have taken part in this nine-week online course since its launch in 2022.
2. Leading Systemic Innovation in Healthcare: this five-day, campus-based course attracts 20–25 participants each time it is run. James is also a tutor on the Academic Health Science Centre Foresight Leadership Programme and the Imperial College & Corndel Healthcare Leadership Development Programme.
Doctoral programme
Congratulations to CHEPI doctoral students Christa Hansen and Alexa Segal who were both awarded their PhD early in 2023.
Imperial College Business School offers 15 fully-funded PhD places each year, for which there is fierce competition. A number of doctoral students choose to conduct their research within CHEPI. Current students are listed here.
“Real-life experience working on satisfying projects with top companies in the healthcare field”
MSc course participant 2023
“Unmissable if you want to be on top of the current trends in healthcare innovation”
Digital Transformation course participant 2022–23
Petya Atanasova
Food environments and noncommunicable diseases. evidence from South Asia Biobank
Faculty of Medicine student
CHEPI supervisors: Prof. Franco Sassi and Prof. Marisa Miraldo
Natalia Kovalevskaya
Impact of school meals in conflict and post-conflict zones on child nutrition, health and local food security.
Faculty of Medicine student
CHEPI supervisor: Prof. Franco Sassi
Shutian Liu
The roots of health inequality from behavioural and neuroeconomics
Business School student
CHEPI supervisor: Prof. Franco Sassi
Narges Mohammadi
Optimal hearing loss monitoring and infection treatment planning for patients with cystic fibrosis. Runner-up June 2023 for ICBS Operations & Analytics Best PhD Paper.
Business School student
CHEPI supervisor: Dr. Reza Skandari
Projects – Internal collaborations
Natural Sciences
Maxime Roche
Essays on the drivers of unhealthy dietary choices
Business School student
CHEPI supervisors: Prof. Franco Sassi and Dr. Laure de Preux
Jiajia Zhan
Digital innovation in healthcare delivery.
Business School student
CHEPI supervisor: Prof. Dame Carol Propper
Zhengnan Zhu
Patient movement, prescription behaviour and innovation diffusion
Business School student
CHEPI supervisor: Prof. Marisa Miraldo
School
CHEPI-affiliated publications
August 2022 – March 2024
Articles
1. Aarthi GR, Mehreen Begum TS, Moosawi SA, Kusuma D, Ranjani H, Paradeepa R, Padma V, Mohan V, Anjana RM, Fecht D. Associations of the built environment with type 2 diabetes in Asia: a systematic review. BMJ Open 2023;13:e065431. doi: 10.1136/bmjopen-2022-065431
2. Alexander JT, Staab EM, Wan W, Franco M, Knitter A, Skandari MR, Bolen S, Maruthur NM, Huang ES, Philipson LH, et al. The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med 2022;37:415-438. doi: 10.1007/s11606-021-07105-9
3. Alexander JT, Staab EM, Wan W, Franco M, Knitter A, Skandari MR, Bolen S, Maruthur NM, Huang ES, Philipson LH, et al. Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022;37:439-448. doi: 10.1007/s11606-02107227-0
4. Antonacci G, Ahmed L, Lennox L, Rigby S, CoroniniCronberg S. Oral health promotion in acute hospital setting: a quality improvement programme. BMJ Open Qual. 2023;12:e002166. doi: doi: 10.1136/ bmjoq-2022-002166
5. Antonacci G, Benevento E, Bonavitacola S, Cannavacciuolo L, Foglia E, Fusi G, Garagiola E, Ponsiglione C, Stefanini A. Healthcare professional and manager perceptions on drivers, benefits, and challenges of telemedicine: results from a crosssectional survey in the Italian NHS. BMC Health Serv Res. 2023;23. doi: 10.1186/s12913-023-10100-x
6. Antonacci G, Whitney J, Harris M, Reed JE. How do healthcare providers use national audit data for improvement? BMC Health Serv Res. 2023;23. doi: 10.1186/s12913-023-09334-6
7. Azupogo F, Abizari AR, Aurino E, Gelli A, Osendarp SJM, Bras H, Feskens EJM, Brouwer ID. Trends and factors associated with the nutritional status of adolescent girls in Ghana: a secondary analysis of the 2003-2014 Ghana demographic and health survey (GDHS) data. Public Health Nutr. 2022;25:1912-1927. doi: 10.1017/S1368980021003827
8. Barrenho E, Halmai R, Miraldo M, Tzintzun I, Raïs Ali S, Toulemon L, Dupont JCK, Rochaix L. Inequities in cancer drug development in terms of unmet medical need. Soc Sci Med. 2022;302. doi: 10.1016/j. socscimed.2022.114953
9. Bowman K, Cadman T, Goncalves Soares A, Robinson O, Hughes A, Heron J, Segal AB, Huerta MC, Howe LD. Mediators of the association between childhood body mass index and educational attainment: analysis of a UK prospective cohort study. Pediatr Obes. 2023;18: e13014. doi: 10.1111/ijpo.13014
10. Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M, Gilbert N, Purshouse R, Robinson S, Dodd PJ, Strong M, Paisley S, Smith R, Briggs A, Shahab L, Occhipinti JA, Lawson K, Bayley T, Smith R, Boyd J, Kadirkamanathan V, Cookson R, Hernandez-Alava M, Jackson CH, Karapici A, Sassi F, Scarborough P, Siebert U, Silverman E, Vale L, Walsh C, Brennan A. Guidance on the use of complex systems models for economic evaluations of public health interventions. Health Econ. 2023;32: 1603-25. doi: 10.1002/hec.4681
11. Case KK, Pineda E, Olney J, Segal AB, Sassi F. The sugar tax in Bermuda: a mixed methods study of general population and key stakeholder perceptions. BMC Public Health. 2022;22: 1557. doi: 10.1186/ s12889-022-13945-9
12. Choi JG, Winn AN, Skandari MR, Franco MI, Staab EM, Alexander J, Wan W, Zhu M, Huang ES, Philipson L, Laiteerapong N. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists A CostEffectiveness Study. Ann Intern Med. 2022;175: 1392-+. doi: 10.7326/M21-2941
13. Chen J, Miraldo M. The impact of hospital price and quality transparency tools on healthcare spending: a systematic review. Health Econ Rev. 2022;12. doi: 10.1186/s13561-022-00409-4
14. Cole TJ, Lobstein T. An improved algorithm to harmonize child overweight and obesity prevalence rates. Pediatr Obes. 2023;18: e12970. doi: 10.1111/ ijpo.12970.
15. D’Aeth JC, Ghosal S, Grimm F, Haw D, Koca E, Lau K, Liu H, Moret S, Rizmie D, Smith PC, Forchini G, Miraldo M, Weisemann W. Optimal Hospital Care Scheduling During the SARS-CoV-2 Pandemic. Manage Sci 2023;69:5923-5947. doi: 10.1287/mnsc.2023.4679
16. de Preux L, Rizmie D, Fecht D, Gulliver J, Wang W. Does it measure up? A comparison of pollution exposure assessment techniques applied across hospitals in England. Int J Environ Res Public Health. 2023;20: 3852. doi: 10.3390/ijerph20053852.
17. Emmert-Fees KMF, Capacci S, Sassi F, Mazzocchi M, Laxy M. Estimating the impact of nutrition and physical activity policies with quasi-experimental methods and simulation modelling: an integrative review of methods, challenges and synergies. Eur J Public Health 2022;32:IV84-IV91. doi: 10.1093/eurpub/ckac051
18. Fernández-Barrés S, Robinson O, Fossati S, Márquez S, Basagaña X, de Bont J, de Castro M, Donaire-Gonzalez D, Maitre L, Nieuwenhuijsen M, Romaguera D, Urquiza J, Chatzi L, Iakovides M, Vafeiadi M, Grazuleviciene R, Dedele A, Andrusaityte S, Aasvang GM, Evandt J, Krog NH, Lepeule J, Heude B, Wright J, McEachan RRC, Sassi F, Vineis P, Vrijheid M. Urban environment and health behaviours in children from six European countries. Environ Int. 2022;165. doi: 10.1016/j.envint.2022.107319
19. Firpo S, Galvao AF, Kobus M, Parker T, Rosa-Dias P. Loss aversion and the welfare ranking of policy interventions. J Economet. 2023. doi: 10.1016/j. jeconom.2023.105643
20. Freitas D, Alner S, Demetrescu C, Antonacci G, Proudlove N. Time to be more efficient: reducing wasted transthoracic echocardiography (TTE) diagnostic appointment slots at Guy’s and St Thomas’ NHS Trust. BMJ Open Qual. 2023;12. doi: 10.1136/ bmjoq-2023-002317
21. Gama F, Tyskbo D, Nygren J, Barlow J, Reed J, Svedberg P. Implementation Frameworks for Artificial Intelligence Translation into Health Care Practice: Scoping Review. J Med Internet Res. 2022;24. doi: 10.2196/32215
22. Gentilini A, Miraldo M. The role of patient organisations in research and development: Evidence from rare diseases. Soc Sci Med. 2023; 338. doi: 10.1016/j. socscimed.2023.116332
23. Goiana-da-Silva F, Cruz-e-Silva D, Rito A, Lopes C, Muc M, Darzi A, Araújo F, Miraldo M, Morais Nunes A, Allen LN. Modeling the health impact of legislation to limit the salt content of bread in Portugal: A macro simulation study. Front Public Health. 2022; 10. doi: 10.3389/ fpubh.2022.876827
24. Grépin KA, Chukwuma A, Holmlund M, Vera-Hernandez M, Wang Q, Rosa-Dias P. Estimating the impact of trained midwives and upgraded health facilities on institutional delivery rates in Nigeria using a quasiexperimental study design. BMJ Open. 2022; 12. doi: 10.1136/bmjopen-2021-053792
25. Handakas E, Xu Y, Segal AB, Huerta MC, Bowman K, Howe LD, Sassi F, Robinson O. Molecular mediators of the association between child obesity and mental health. Front Genet. 2022; 13. doi: 10.3389/ fgene.2022.947591
26. Handakas E, Chang K, Khandpur N, Vamos EP, Millett C, Sassi F, Vineis P, Robinson O. Metabolic profiles of ultra-processed food consumption and their role in obesity risk in British children. Clin Nutr. 2022;41: 253748. doi: 10.1016/j.clnu.2022.09.002
27. Hidefjall P, Laurell H, Johansson J, Barlow J. Institutional logics and the adoption and implementation of remote patient monitoring. Innov Organ Manag 2023; 1-20. doi. org/10.1080/14479338.2022.2162907
28. Junghans C, Antonacci G, Williams A, Harris M. Learning from the universal, proactive outreach of the Brazilian Community Health Worker model: impact of a Community Health and Wellbeing Worker initiative on vaccination, cancer screening and NHS health check uptake in a deprived community in the UK. BMC Health Serv Res. 2023; 23. doi: 10.1186/s12913-023-10084-8
29. Kaye N, Purdon M, Schofield R, Antonacci G, Proudlove N. Clinical-scientist-led transoesophageal echocardiography (TOE): Using extended roles to improve the service. BMJ Open Qual. 2023; 12. doi: 10.1136/bmjoq-2023-002268
30. Lambourg E, Siani C, de Preux L. Use of a high-volume prescription database to explore health inequalities in England: assessing impacts of social deprivation and temperature on the prescription volume of medicines. J Public Health. 2022; 30:2231-2242. doi: 10.1007/ s10389-021-01691-y
31. Lennox L, Antonacci G, Harris M, Reed J. Unpacking the ‘process of sustaining’—identifying threats to sustainability and the strategies used to address them: a longitudinal multiple case study. Implement Sci Commun. 2023; 4. doi: 10.1186/s43058-023-00445-z
32. Li C, Zhu J, Shan L, Zhou Y, Liu G, Zhu H, Wu Q, Cui Y, Kang Z. Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis. BMC Health Serv Res. 2024; 24. doi: 10.1186/s12913-023-10393-y
33. Lodwick SJ, Antonacci G, Proudlove N. Time is a terrible thing to waste: optimising use of intraoperative monitoring practitioner time towards maximising in-house IOM service provision and reducing spend on external provision. BMJ Open Qual. 2024; 13. doi: 10.1136/bmjoq-2023-002492
34. Malacarne D, Handakas E, Robinson O, Pineda E, Saez M, Chatzi L, Fecht D. The built environment as determinant of childhood obesity: A systematic literature review. Obes Rev. 2022; 23. doi: 10.1111/ obr.13385
35. Martinez JA, Sassi F, Moreno LA, Tur JA. Position guidelines and evidence base concerning determinants of childhood obesity with a European perspective. Obes Rev. 2022; 23. doi: 10.1111/obr.13391
36. Martínez-Jiménez M. Parental nonemployment in childhood and children’s health later in life. Econ Hum Biol. 2023; 49. doi: 10.1016/j.ehb.2023.101241
37. Nair V, Auger S, Kochanny S, Howard FM, Ginat D, Pasternak-Wise O, Juloori A, Koshy M, Izumchenko E, Agrawal N, Rosenberg A, Vokes EE, Skandari MR, Pearson AT. Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients with Oropharyngeal Carcinoma. JAMA Netw Open. 2022;5:E227240. doi: 10.1001/ jamanetworkopen.2022.7240
38. Nasution F, Gurning F, Siregar P, Ahsan A, Kusuma D. Implementation of the smoke-free policy in Medan City, Indonesia: Compliance and challenges. Int J Prev Med 2022; 13. doi: 10.4103/ijpvm.IJPVM_106_20
39. Neufeld M, Rovira P, Ferreira-Borges C, Kilian C, Sassi F, Veryga A, Rehm J. Impact of introducing a minimum alcohol tax share in retail prices on alcohol-attributable mortality in the WHO European Region: A modelling study. Lancet Reg Health Eur. 2022;15. doi: 10.1016/j. lanepe.2022.100325
40. Nilsen P, Reed J, Nair M, Savage C, Macrae C, Barlow J, Svedberg P, Larsson I, Lundgren L, Nygren J. Realizing the potential of artificial intelligence in healthcare: Learning from intervention, innovation, implementation and improvement sciences. Front Health Serv. 2022; 2. doi: 10.3389/frhs.2022.961475
41. Paalanen L, Levälahti E, Mäki P, Tolonen H, Sassi F, Ezzati M, Laatikainen T. Association of socioeconomic position and childhood obesity in Finland: A registrybased study. BMJ Open. 2022; 12. doi: 10.1136/ bmjopen-2022-068748
42. Pineda E, Barbosa Cunha D, Taghavi Azar Sharabiani M, Millett C. Association of the retail food environment, BMI, dietary patterns, and socioeconomic position in urban areas of Mexico. PLOS Glob Public Health. 2023; 3:e0001069. doi: 10.1371/journal.pgph.0001069
43. Pineda E, Bouzas C, Arroyo M, Martínez JA, Tur JA. Priorización de políticas alimentarias en España mediante el Índice Food-EPI de entornos alimentarios saludables: panel de expertos. Rev Esp Salud Publica 2023;97.
44. Pineda E, Gressier M, Li D, Brown T, Mounsey S, Olney J, Sassi F. Review: Effectiveness and policy implications of health taxes on foods high in fat, salt, and sugar. Food Policy 2024; 123; 102599 https://doi.org/10.1016/j. foodpol.2024.102599
45. Pineda E, Li J, Li D, Brown T, Bhatia T, Walker IF, Olney J, Sassi F. Lessons on food security from the COVID-19 pandemic in Bermuda. PLOS Glob Public Health. 2024; e0002837. doi: 10.1371/journal.pgph.0002837
46. Pineda E, Poelman MP, Aaspõllu A, Bica M, Bouzas C, Carrano E, De Miguel-Etayo P, Djojosoeparto S, Blenkuš MG, Graca P, Geffert K, Hebestreit A, Helldan A, Henjum S, Huseby CS, Gregório MJ, Kamphuis C, Laatikainen T, Løvhaug AL, Leydon C, Luszczynska A, Mäki P, Martínez PJ, Raulio S, Romaniuk P, Roos G, Salvador C, Sassi F, Silano M, Sotlar I, Specchia ML, Telo de Arriaga M, Terragni L, Torheim LE, Tur JA, von Philipsborn P, Harrington JM, Vandevijvere S. Policy implementation and priorities to create healthy food environments using the Healthy Food Environment Policy Index (Food-EPI): A pooled level analysis across eleven European countries. Lancet Reg Health Eur 2022; 23. doi: 10.1016/j.lanepe.2022.100522
47. Porter J, Boyd C, Skandari MR, Laiteerapong N. Revisiting the time needed to provide adult primary care. J Gen Intern Med 2023;38: 147-55. doi: 10.1007/ s11606-022-07707-x.
48. Ramírez-Rivera DL, Martínez-Contreras T , Rosa C. Villegas-Valle RC, Álvarez- Hernández G, GonzálezFimbres R, Bello-Chavolla OY, Pineda E, EsparzaRomero J, Haby MM, Díaz-Zavala RG. Effectiveness of a school-based obesity prevention program on the BMI Z-score and body fat at 6 months in Mexican children: study protocol of a cluster randomized controlled trial: Effectiveness of a school-based obesity prevention program. Biotecnia. 2023;25: 71-8. doi.org/10.18633/ biotecnia.v25i3.2074
49. Rizmie D, de Preux L, Miraldo M, Atun R. Impact of extreme temperatures on emergency hospital admissions by age and socio-economic deprivation in England. Soc Sci Med. 2022;308: 115193 doi: 10.1016/j. socscimed.2022.115193
50. Roche M, Alvarado M, Sandoval RC, Gomes FDS, Paraje G. Comparing taxes as a percentage of sugarsweetened beverage prices in Latin America and the Caribbean. Lancet Reg Health Am. 2022; 11. doi: 10.1016/j.lana.2022.100257
51. Roche M, Sandoval RC, Monteiro MG. Comparing taxes on alcoholic beverages in the Region of the Americas. Addiction. 2023; 118:1389-1395. doi: 10.1111/ add.16146
52. Sangeorzan I, Antonacci G, Martin A, Grodzinski B, Zipser CM, Murphy RKJ, Andriopoulou P, Cook CE, Anderson DB, Guest J, et al. Toward Shared DecisionMaking in Degenerative Cervical Myelopathy: Protocol for a Mixed Methods Study. JMIR Res Prot. 2023; 12. doi: 10.2196/46809
53. Sassi F. More public health scrutiny is needed on government actions: a comment on Mitchell and McCambridge (2023). J Stud Alcohol Drugs 2023;84:337-338. doi: 10.15288/jsad.23-00021
54. Savoia E, Harriman NW, Piltch-Loeb R, Bonetti M, Toffolutti V, Testa MA. Exploring the Association between Misinformation Endorsement, Opinions on the Government Response, Risk Perception, and COVID-19 Vaccine Hesitancy in the US, Canada, and Italy. Vaccines. 2022; 10. doi: 10.3390/vaccines10050671
55. Smith LK, van Blankenstein E, Fox G, Seaton SE, Martínez-Jiménez M, Petrou S, Battersby C. Effect of national guidance on survival for babies born at 22 weeks’ gestation in England and Wales: population based cohort study. BMJ Med. 2023;2: e000579. doi: 10.1136/bmjmed-2023-000579
56. Svedberg P, Reed J, Nilsen P, Barlow J, Macrae C, Nygren J. Toward Successful Implementation of Artificial Intelligence in Health Care Practice: Protocol for a Research Program. JMIR Res Prot. 2022;11. doi: 10.2196/34920
57. Vineis P, Handakas E, Alfano R, Millett C, Fecht D, Chatzi L, Plusquin M, Nawrot T, Richiardi L, Barros H, Vrijheid M, Sassi F, Robinson O. The contribution to policies of an exposome-based approach to childhood obesity. Exposome. 2023;3:osad006. doi: 10.1093/ exposome/osad006
58. Warner M, Burn S, Stoye G, Aylin PP, Bottle A, Propper C. Socioeconomic deprivation and ethnicity inequalities in disruption to NHS hospital admissions during the COVID-19 pandemic: a national observational study. BMJ Qual Saf. 2022;31:590-598. doi: 10.1136/ bmjqs-2021-013942
59. Wellappuli NT, Perera HSR, Chang T, Kasthuriratne G, Gunawardena NS. Coverage and equity of essential care services among stroke survivors in the Western Province of Sri Lanka: a community-based crosssectional study. BMC Health Serv Res. 2022; 22. doi: 10.1186/s12913-022-08404-5
60. Wellappuli NT, Perera HSR, Kasthuriratne G, Chang T, Gunawardena NS. Adaptation and validation of the Longer-term Unmet Needs after Stroke (LUNS) monitoring tool in Sri Lanka. BMC Public Health. 2023; 23. doi: 10.1186/s12889-023-16636-1
61. Williams A, Lennox L, Harris M, Antonacci G Supporting translation of research evidence into practice: the use of Normalisation Process Theory to assess and inform implementation within randomised controlled trials: a systematic review. Implement Sci 2023; 18. doi: 10.1186/s13012-023-01311-1
Book chapters
1. Dzhygyr Y, Maynzynk K, Murphy A, Propper C. The health system. In: Gorodnickcenko Y, Sologub I, (eds.) Rebuilding Ukraine: principles and policies. Centre for Economic Policy Research; 2022: 361-384.
2. Sandoval RC, Roche M, Perucic AM, Alvarado M, Belausteguigoitia I, Galicia L, Paraje G. Monitoring and measuring health taxes. In: Lauer J, Sassi F, Soucat A, Vigo A, (eds.) Health taxes: policy and practice. London: World Scientific Publishing; 2023:351-399.
3. Sassi F, Cafrine R, Colchero MA, Prasad N. Fiscal measures for NCD prevention and control. In: Banatvala N, Bovet P, (eds.) Noncommunicable diseases: a compendium. Routledge; 2023:302-307. https://doi. org/10.4324/9781003306689
Books and reports
1. Barlow J, Hofer M, Criscuolo P, ter Wal A. Sectoral systems of innovation and the UK’s competitiveness Imperial College London, 2023
2. Lauer JA, Sassi F, Soucat ALB, Vigo A. (Eds) Health taxes: policy and practice. World Scientific Publishing Europe; 2023.
3. Propper C Socio-economic inequality in the distribution of health care in the UK. IFS Deaton Review of Inequalities London: Institute for Fiscal Studies; 2022.
4. Propper C, Stoye G, Warner M. The effects of pension reforms on physician labour supply: evidence from the English NHS. London: Institute for Fiscal Studies; 2023
Conference papers (published)
1. Hansen C, Miraldo M, Hauck K. Does community HIV combination prevention (HPTN 071 (PopART)) impact healthcare inequity? Eur J Public Health. 2022; 32(Suppl 3) https://europepmc.org/article/PMC/PMC9835148
2. Segal A, Miraldo M, de Preux L. Parenting do’s and don’ts: the effects of parenting styles on child’s weight status: meeting abstract LBO01B. Paper/Poster presented at: International Congress on Obesity 2022; Melbourne, Australia. Obes Rev 2022; 22(S2). https:// doi-org.iclibezp1.cc.ic.ac.uk/10.1111/obr.13502
About CHEPI
The Centre for Health Economics and Policy Innovation was set up in 2017 under its current Director, Professor Franco Sassi. It is hosted by the Department for Economics and Public Policy within Imperial College Business School. CHEPI aims to research and analyse incentives and environments that encourage individuals, organisations, business, and government to improve people’s health.
Over the past five years, CHEPI has become the most research-active centre within the Business School, attracting £15m in grant money during that period.
CHEPI has four pillars of operation:
Research
– Teaching
– People
Relations
CHEPI specialises in national, European and international research in public health economics and policy. Over the past few years CHEPI has developed a particular emphasis on food, nutrition, and obesity.
CHEPI researchers have also been active in investigating the economic impacts of Covid-19 and continue to explore pandemic preparedness.
Our funders
Grateful thanks for funding our research this year go to:
